Group 1 - Aladdin Biochemical Technology Co., Ltd. experienced a stock price increase of 5.18%, reaching 12.99 CNY per share, with a trading volume of 100 million CNY and a turnover rate of 2.37%, resulting in a total market capitalization of 4.321 billion CNY [1] - The company, established on March 16, 2009, and listed on October 26, 2020, focuses on the research, production, and sales of reagents, with its main revenue sources being research reagents (96.96%), laboratory consumables (2.15%), and other supplementary products (0.89%) [1] Group 2 - Morgan Stanley's fund, specifically the Morgan Stanley Yu Yue An He Mixed A Fund (009893), has a significant position in Aladdin, having increased its holdings by 59,700 shares in the second quarter, totaling 275,900 shares, which represents 5.24% of the fund's net value, making it the sixth-largest holding [2] - The Morgan Stanley Yu Yue An He Mixed A Fund was established on September 24, 2020, with a current size of 28.9066 million CNY, achieving a year-to-date return of 22.61% and a one-year return of 35.66%, ranking 4240 out of 8171 and 4277 out of 8004 in its category, respectively [2]

Core Viewpoint - Aladdin's stock price has shown fluctuations in recent trading periods, with a current market capitalization of 4.194 billion yuan and a notable increase in share price of 11.27% year-to-date [1][2]. Financial Performance - For the first half of 2025, Aladdin achieved a revenue of 275 million yuan, reflecting a year-on-year growth of 15.45%, while the net profit attributable to shareholders decreased by 39.79% to 28.4635 million yuan [2]. - Cumulatively, Aladdin has distributed 241 million yuan in dividends since its A-share listing, with 150 million yuan distributed over the past three years [3]. Stock Market Activity - As of September 26, Aladdin's stock rose by 2.11% to 12.61 yuan per share, with a trading volume of 13.1574 million yuan and a turnover rate of 0.32% [1]. - The net inflow of main funds was 1.6862 million yuan, with large orders accounting for 19.87% of purchases and 7.05% of sales [1]. Shareholder Structure - As of June 30, 2025, Aladdin had 12,500 shareholders, an increase of 22.88% from the previous period, with an average of 26,670 circulating shares per shareholder, a decrease of 2.42% [2]. - Among the top ten circulating shareholders, several funds have adjusted their holdings, with notable changes in the shares held by various funds [3].

Group 1 - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., announced that part of the bank account funds of its subsidiary, Kasma Holdings Ltd., have been frozen due to a contractual dispute with Tianjin Rongda Weiye Technology Development Co., Ltd. [3][4] - The total amount frozen is 9,002,802.54 yuan, which represents 0.84% of the company's audited net assets as of December 31, 2024, and 0.87% of the net assets as of June 30, 2025. It also accounts for 1.93% of the company's audited cash and cash equivalents as of December 31, 2024, and 2.86% as of June 30, 2025. [2][4] - The company stated that the frozen funds constitute a small proportion of its cash resources and will not have a significant adverse impact on its production and operational activities. [2][4] Group 2 - The company is taking effective legal measures to resolve the dispute and aims to address the issue of the frozen account funds promptly, ensuring the protection of the company's and investors' legal rights. [5] - The company emphasizes that all information should be verified through its designated disclosure media, including Shanghai Securities News and Securities Times, as well as the Shanghai Stock Exchange website. [5]

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-059 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于公司的控股子公司部分银行账户资金被冻结 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要风险提示： 上海阿拉丁生化科技股份有限公司（以下简称"阿拉丁"或"公司"） 的控股子公司喀斯玛控股有限公司（以下简称"喀斯玛控股"）的部分银行账户 资金被冻结，喀斯玛控股被冻结金额合计为 9,002,802.54 元，上述金额占公司 合并报表最近一年（2024 年 12 月 31 日）经审计净资产的 0.84%，占公司 2025 年半年度末（2025 年 6 月 30 日）净资产的 0.87%，占公司合并报表最近一年（2024 年 12 月 31 日）经审计货币资金的 1.93%，占公司 2025 年半年度末（2025 年 6 月 30 日）货币资金的 2.86%。本次被冻结的账户资金占公司货币资金比例较 ...

Core Viewpoint - Aladdin announced that some bank accounts of its subsidiary, Kasma Holdings Limited, have been frozen due to a contractual dispute with Tianjin Rongda Weiye Technology Development Co., Ltd. [1] Financial Impact - The total amount frozen is 9.0028 million yuan, which is a small proportion of the company's cash funds [1] - The freezing of funds is not expected to have a significant adverse impact on the company's production and operational activities [1]

Core Viewpoint - Aladdin announced its participation in the auction for an 81.96% stake in Kasma Holdings, owned by the Chinese Academy of Sciences Holdings, with a transaction price of 260.989109 million yuan [1] Group 1 - The fourth meeting of the fourth board of directors and the twenty-fourth meeting of the fourth supervisory board will be held on July 4, 2025 [1] - The company has been approved to participate in the auction for the stake in Kasma Holdings [1] - Kasma Holdings has completed the industrial and commercial registration procedures recently [1]

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-058 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 2025 年 7 月 4 日，上海阿拉丁生化科技股份有限公司（以下简称"公司"） 召开第四届董事会第四十次会议及第四届监事会第二十四次会议，审议通过了 《关于参与竞拍中国科学院控股有限公司持有的喀斯玛控股有限公司 81.96%的 股权的议案》，同意公司参与中国科学院控股有限公司（以下简称"中科院控股"） 所持标的股份的竞拍。根据北京产权交易所出具的《交易签约通知书》，公司成 为中科院控股公开挂牌出售其持有的喀斯玛控股有限公司（以下简称"喀斯玛控 股"）有 81.96%的股权的受让方，成交价格为 26,098.9109 万元。具体内容详见 公司于 2025 年 8 月 9 日在上海证券交易所网站(www.sse.com.cn)披露的《上海 阿拉丁生化科技股份有限公司关于参与竞拍喀斯玛控股有限公司股权的进展公 告》（公告编号：2025-054）。 二、交易进展 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或 ...

Company Overview - Aladdin Biochemical Technology Co., Ltd. is located at 36 Nanta, Xinjinqiao Road, Pudong New District, Shanghai, established on March 16, 2009, and listed on October 26, 2020. The company specializes in the research, production, and sales of reagents, with main business revenue composition: 96.96% from research reagents, 2.15% from laboratory consumables, and 0.89% from other sources [1]. Stock Performance - As of September 3, Aladdin's stock price decreased by 0.92%, trading at 12.91 CNY per share, with a total transaction volume of 86.79 million CNY and a turnover rate of 2.00%. The total market capitalization stands at 4.294 billion CNY. The stock has experienced a continuous decline for 8 days, with a cumulative drop of 18.6% during this period [1]. Fund Holdings - Morgan Stanley's fund has a significant position in Aladdin, with the "Morgan Stanley Youyue Anhe Mixed A" fund (009893) increasing its holdings by 59,700 shares in the second quarter, totaling 275,900 shares, which accounts for 5.24% of the fund's net value, ranking it as the sixth-largest holding. The estimated floating loss today is approximately 33,100 CNY, with a total floating loss of 813,800 CNY during the 8-day decline [2]. Fund Performance - The "Morgan Stanley Youyue Anhe Mixed A" fund was established on September 24, 2020, with a current size of 28.9066 million CNY. Year-to-date returns are 20.64%, ranking 3666 out of 8180 in its category, while the one-year return is 31.74%, ranking 4447 out of 7967. Since inception, the fund has incurred a loss of 28.99% [2]. Fund Manager Information - The fund manager of "Morgan Stanley Youyue Anhe Mixed A" is Zhao Weijie, who has been in the position for 4 years and 185 days. The total asset size under management is 305 million CNY, with the best fund return during his tenure being 23.35% and the worst being -31% [2].

Summary of Key Points Core Viewpoint - The company plans to utilize part of its temporarily idle raised funds for cash management to enhance fund efficiency and generate additional returns for the company and its shareholders [1][5]. Fundraising Overview - The company issued a total of 3.874 million convertible bonds at a face value of RMB 100 each, raising a total of RMB 387.4 million, with a net amount of RMB 373.38 million after deducting issuance costs of RMB 14.02 million [1][2]. Fund Management and Usage - All raised funds have been deposited into a special account, and the company has established a three-party and four-party supervision agreement with the sponsor and the bank [2][3]. - The company plans to invest up to RMB 150 million of the temporarily idle funds for cash management, ensuring that it does not affect the normal progress of fundraising investment projects [3][4]. Investment Strategy - The cash management will focus on low-risk investment products, and the company will ensure that the investment does not interfere with the ongoing projects [4][5]. - The board of directors has authorized the chairman to make investment decisions within the approved limits and timeframe [4][5]. Impact on Company - The cash management of idle funds is expected to improve fund utilization efficiency without affecting the company's main business operations, thereby potentially enhancing overall performance and returns for shareholders [4][5][6]. Compliance and Approval - The proposal for cash management has been approved by both the board of directors and the supervisory board, confirming compliance with relevant laws and regulations [5][6].

Group 1 - The company Aladdin (688179.SH) reported a revenue of 275 million yuan for the first half of 2025, representing a year-on-year growth of 15.45% [1] - The net profit attributable to the parent company was 28.46 million yuan, showing a year-on-year decline of 39.79% [1] - The net profit excluding non-recurring items was 27.8 million yuan, also reflecting a year-on-year decrease of 39.87% [1] - The basic earnings per share stood at 0.09 yuan [1]